-
1.发明申请公开(公告)号：US20090253634A1
公开(公告)日：2009-10-08
申请号：US12064116
申请日：2006-08-21
申请人： Mark G. Currie , Shalina Mahajan-Miklos , Angelika Fretzen , Li Jing Sun , Caroline Kurtz , G. Todd Milne , Thea Norman , Shannon Roberts , E. Kelly Sullivan
发明人： Mark G. Currie , Shalina Mahajan-Miklos , Angelika Fretzen , Li Jing Sun , Caroline Kurtz , G. Todd Milne , Thea Norman , Shannon Roberts , E. Kelly Sullivan
CPC分类号： C07K7/08 , C07K14/4705
摘要： The present invention features compositions and related methods for treating IBS and other gastrointestinal disorders and conditions (e.g., gastrointestinal motility disorders, functional gastrointestinal disorders, gastnoesophageal reflux disease (GERD), duodenogastric reflux, Crohn's disease, ulcerative colitis, Inflammatory bowel disease, functional heartburn, dyspepsia (including functional dyspepsia or nonulcer dyspepsia), gastroparesis, chronic intestinal pseudo-obstruction (or colonic pseudo-obstruction), and disorders and conditions associated with constipation, e.g. constipation associated with use of opiate pain killers, post-surgical constipation (post-operative ileus), and constipation associated with neuropathic disorders as well as other conditions and disorders using peptides and other agents that activate the guanylate cyclase C (GC-C) receptor.
摘要翻译： 本发明的特征在于用于治疗IBS和其他胃肠道疾病和病症（例如胃肠蠕动障碍，功能性胃肠道疾病，胃食管反流病（GERD），十二指肠胃反流，克罗恩病，溃疡性结肠炎，炎性肠病，功能性胃灼热的组合物和相关方法 ，消化不良（包括功能性消化不良或非溃疡性消化不良），胃轻瘫，慢性肠假性梗阻（或结肠假性梗阻）以及与便秘相关的疾病和病症，例如与使用阿片类止痛药相关的便秘，手术后便秘（post 手术肠梗阻）和与神经性疾病相关的便秘以及使用活化鸟苷酸环化酶C（GC-C）受体的肽和其他试剂的其它病症和病症。
-
2.发明申请公开(公告)号：US20090062207A1
公开(公告)日：2009-03-05
申请号：US11054071
申请日：2005-02-08
申请人： Mark G. Currie , Shalina Mahajan-Miklos , Angelika Fretzen , Li Jing Sun , Caroline Kurtz , Thea Norman , G. Todd Milne
发明人： Mark G. Currie , Shalina Mahajan-Miklos , Angelika Fretzen , Li Jing Sun , Caroline Kurtz , Thea Norman , G. Todd Milne
CPC分类号： C07K5/1016 , A61K38/00 , C07K7/06 , C07K7/08 , C07K14/195 , C07K14/245 , C07K14/705
摘要： The present invention features compositions and related methods for treating IBS and other gastrointestinal disorders and conditions (e.g., gastrointestinal motility disorders, functional gastrointestinal disorders, gastroesophageal reflux disease (GERD), duodenogastric reflux, Crohn's disease, ulcerative colitis, Inflammatory bowel disease, functional heartburn, dyspepsia (including functional dyspepsia or nonulcer dyspepsia), gastroparesis, chronic intestinal pseudo-obstruction (or colonic pseudo-obstruction), and disorders and conditions associated with constipation, e.g., constipation associated with use of opiate pain killers, post-surgical constipation (post-operative ileus), and constipation associated with neuropathic disorders as well as other conditions and disorders using peptides and other agents that activate the guanylate cyclase C (GC-C) receptor.
摘要翻译： 本发明的特征在于用于治疗IBS和其他胃肠道疾病和病症（例如胃肠蠕动障碍，功能性胃肠道疾病，胃食管反流病（GERD），十二指肠胃反流，克罗恩病，溃疡性结肠炎，炎性肠病，功能性胃灼热的组合物和相关方法 ，消化不良（包括功能性消化不良或非溃疡性消化不良），胃轻瘫，慢性肠假性梗阻（或结肠假性梗阻）以及与便秘相关的疾病和病症，例如与使用阿片类止痛药相关的便秘，手术后便秘（ 术后肠梗阻）和与神经性疾病相关的便秘以及使用活化鸟苷酸环化酶C（GC-C）受体的肽和其它试剂的其它病症和障碍。
-
3.发明授权公开(公告)号：US07772188B2
公开(公告)日：2010-08-10
申请号：US11054071
申请日：2005-02-08
申请人： Mark G. Currie , Shalina Mahajan-Miklos , Angelika Fretzen , Li Jing Sun , Caroline Kurtz , Thea Norman , G. Todd Milne
发明人： Mark G. Currie , Shalina Mahajan-Miklos , Angelika Fretzen , Li Jing Sun , Caroline Kurtz , Thea Norman , G. Todd Milne
IPC分类号： A61K38/10
CPC分类号： C07K5/1016 , A61K38/00 , C07K7/06 , C07K7/08 , C07K14/195 , C07K14/245 , C07K14/705
摘要： The present invention features compositions and related methods for treating IBS and other gastrointestinal disorders and conditions (e.g., gastrointestinal motility disorders, functional gastrointestinal disorders, gastroesophageal reflux disease (GERD), duodenogastric reflux, Crohn's disease, ulcerative colitis, Inflammatory bowel disease, functional heartburn, dyspepsia (including functional dyspepsia or nonulcer dyspepsia), gastroparesis, chronic intestinal pseudo-obstruction (or colonic pseudo-obstruction), and disorders and conditions associated with constipation, e.g., constipation associated with use of opiate pain killers, post-surgical constipation (post-operative ileus), and constipation associated with neuropathic disorders as well as other conditions and disorders using peptides and other agents that activate the guanylate cyclase C (GC-C) receptor.
摘要翻译： 本发明的特征在于用于治疗IBS和其他胃肠道疾病和病症（例如胃肠蠕动障碍，功能性胃肠道疾病，胃食管反流病（GERD），十二指肠胃反流，克罗恩病，溃疡性结肠炎，炎性肠病，功能性胃灼热的组合物和相关方法 ，消化不良（包括功能性消化不良或非溃疡性消化不良），胃轻瘫，慢性肠假性梗阻（或结肠假性梗阻）以及与便秘相关的疾病和病症，例如与使用阿片类止痛药相关的便秘，手术后便秘（ 术后肠梗阻）和与神经性疾病相关的便秘以及使用活化鸟苷酸环化酶C（GC-C）受体的肽和其它试剂的其它病症和障碍。
-
公开(公告)号：US07494979B2
公开(公告)日：2009-02-24
申请号：US11054072
申请日：2005-02-08
CPC分类号： C07K7/08 , A61K38/00 , C07K14/4705
摘要： Compositions and related methods for treating IBS and other gastrointestinal disorders and conditions (e.g., gastrointestinal motility disorders, functional gastrointestinal disorders, gastroesophageal reflux disease (GERD), duodenogastric reflux, Crohn's disease, ulcerative colitis, inflammatory bowel disease, functional heartburn, dyspepsia (including functional dyspepsia or nonulcer dyspepsia), gastroparesis, chronic intestinal pseudo-obstruction (or colonic pseudoobstruction), and disorders and conditions associated with constipation, e.g., constipation associated with use of opiate pain killers, post-surgical constipation, and constipation associated with neuropathic disorders as well as other conditions and disorders are described. The compositions feature peptides that activate the guanylate cyclase C (GC-C) receptor.
摘要翻译： 用于治疗IBS和其他胃肠道疾病和病症的组合物和相关方法（例如，胃肠动力障碍，功能性胃肠道疾病，胃食管反流病（GERD），十二指肠胃反流，克罗恩病，溃疡性结肠炎，炎性肠病，功能性胃灼热，消化不良（包括 功能性消化不良或非溃疡性消化不良），胃轻瘫，慢性肠假性梗阻（或结肠假性梗阻）以及与便秘相关的疾病和病症，例如与使用阿片类止痛药相关的便秘，手术后便秘和与神经性疾病相关的便秘 描述了其它条件和病症，组合物具有激活鸟苷酸环化酶C（GC-C）受体的肽。
-
公开(公告)号：US20060094658A1
公开(公告)日：2006-05-04
申请号：US11054072
申请日：2005-02-08
申请人： Mark Currie , Shalina Mahajan-Miklos , Li Sun , Caroline Kurtz
发明人： Mark Currie , Shalina Mahajan-Miklos , Li Sun , Caroline Kurtz
CPC分类号： C07K7/08 , A61K38/00 , C07K14/4705
摘要： Compositions and related methods for treating IBS and other gastrointestinal disorders and conditions (e.g., gastrointestinal motility disorders, functional gastrointestinal disorders, gastroesophageal reflux disease (GERD), duodenogastric reflux, Crohn's disease, ulcerative colitis, inflammatory bowel disease, functional heartburn, dyspepsia (including functional dyspepsia or nonulcer dyspepsia), gastroparesis, chronic intestinal pseudo-obstruction (or colonic pseudoobstruction), and disorders and conditions associated with constipation, e.g., constipation associated with use of opiate pain killers, post-surgical constipation, and constipation associated with neuropathic disorders as well as other conditions and disorders are described. The compositions feature peptides that activate the guanylate cyclase C (GC-C) receptor.
摘要翻译： 用于治疗IBS和其他胃肠道疾病和病症的组合物和相关方法（例如，胃肠动力障碍，功能性胃肠道疾病，胃食管反流病（GERD），十二指肠胃反流，克罗恩病，溃疡性结肠炎，炎性肠病，功能性胃灼热，消化不良（包括 功能性消化不良或非溃疡性消化不良），胃轻瘫，慢性肠假性梗阻（或结肠假性梗阻）以及与便秘相关的疾病和病症，例如与使用阿片类止痛药相关的便秘，手术后便秘和与神经性疾病相关的便秘 描述了其它条件和病症，组合物具有激活鸟苷酸环化酶C（GC-C）受体的肽。
-
公开(公告)号：US20060029568A1
公开(公告)日：2006-02-09
申请号：US11102576
申请日：2005-04-07
IPC分类号： A61K31/74
CPC分类号： A61K31/74 , A61K31/795 , A61K38/14 , Y02A50/469 , Y02A50/47 , Y02A50/471 , Y02A50/473 , Y02A50/475 , Y02A50/478 , Y02A50/481 , A61K2300/00 , A61K31/415
摘要： The present invention relates to a method of inhibiting a toxin in an animal, such as a human, by administering to the animal a therapeutically effective amount of a polymer having a plurality of pendant acid functional groups which are directly attached to the polymer backbone or attached to the polymer backbone by a spacer group. The spacer group can have a length in the range from 0 to about 20 atoms. The toxin is, typically, an exotoxin secreted by a pathogenic microorganism, such as a bacterium.
-
7.发明申请Method for Modulating the Pharmacodynamic Effect of Orally Administered Guanylate Cyclase Receptor Agonists 审中-公开调节口服胍基环加酶受体激动剂的药效学方法公开(公告)号：US20130045239A1
公开(公告)日：2013-02-21
申请号：US13390123
申请日：2010-08-13
申请人： Jeffrey Johnston , Caroline Kurtz
发明人： Jeffrey Johnston , Caroline Kurtz
CPC分类号： A61K38/10 , A61K9/2009 , A61K9/2013 , A61K9/2054 , A61K9/485 , A61K9/4858 , A61K9/4866 , A61K38/00
摘要： A method of modulating the pharmacodynamic effect of a GC-C receptor agonist polypeptide formulation in a subject in need of such treatment is disclosed, The method comprises administering the GC-C receptor agonist polypeptide formulation to the subject before the ingestion of food.
摘要翻译： 公开了在需要这种治疗的受试者中调节GC-C受体激动剂多肽制剂的药效学作用的方法。该方法包括在摄取食物之前向受试者施用GC-C受体激动剂多肽制剂。
-
公开(公告)号：US06482402B1
公开(公告)日：2002-11-19
申请号：US09568825
申请日：2000-05-11
申请人： Caroline Kurtz , Thomas X. Neenan
发明人： Caroline Kurtz , Thomas X. Neenan
IPC分类号： A61K3174
CPC分类号： A61K45/06 , A61K31/74 , A61K2300/00
摘要： The present invention relates to antimicrobial compositions including pharmaceutical compositions and treatment regimens for preventing or treating a microbial infection in a mammal, such as a human, by administering to the mammal, a therapeutically effective amount of a polymer and a therapeutically effective amount of an antibacterial agent.
摘要翻译： 本发明涉及包含用于预防或治疗哺乳动物（例如人）的微生物感染的药物组合物和治疗方案的抗微生物组合物，其通过向哺乳动物施用治疗有效量的聚合物和治疗有效量的抗菌剂 代理商
-
-
-
-
-
-
-
搜索结果
8 条记录 (耗时 0.044 秒)
